stockcue

TRVI (Trevi Therapeutics, Inc.): Stockcue Score 39/100 — Weak profile · Valuation 10/100 · Financial health 68/100 · price $17.86. Full report with peer comparison, earnings trends and AI analysis below.

Fetching report — first lookup can take ~5s